Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nicholas Pulliam
An Effective Epigenetic-Parp Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA-mutations
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors
Frontiers in Oncology
Cancer Research
Oncology
PARP Inhibitor Treatment in Ovarian and Breast Cancer
Current Problems in Cancer
Cancer Research
Oncology
PARP Inhibitors: Extending Benefit Beyond BRCA Mutant Cancers
Clinical Cancer Research
Cancer Research
Oncology
A Unique Subset of Epithelial Ovarian Cancers With Platinum Sensitivity and PARP Inhibitor Resistance
Cancer Research
Cancer Research
Oncology
Search for an Effective Combination of Examination Methods for Detection of Breast Cancers at Screening
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening)
Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
Searching for Microsatellite Mutations in Coding Regions in Lung, Breast, Ovarian and Colorectal Cancers
Oncogene
Cancer Research
Genetics
Molecular Biology
Nectin-2 Is a Potential Target for Antibody Therapy of Breast and Ovarian Cancers
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
The Spectrum of BRCA Mutations and Characteristics of BRCA-associated Breast Cancers in China: Screening of 2,991 Patients and 1,043 Controls by Next-Generation Sequencing
International Journal of Cancer
Cancer Research
Oncology
